CAPTURE

Protocol Title:

A Post-Approval Study of the Guidant Carotid Artery Stent Systems and Embolic Protection System (Carotid rx Acculink/Accunet Post-Approval Trial to Uncover Unanticipated or Rare Events

Working Title:

The purpose of this study is to collect post FDA-approval data on carotid artery stents in patients whose physicians plan to treat them using the Guidant carotid artery stent. The FDA has approved Guidant's Carotid ACCULINK Carotid Stent System and ACCUNET Embolic Protection System (EPS) for treatment of carotid artery stenosis in patients at high risk for carotid endarterectomy.

Carotid Artery Stenting is an endovascular technology that allows less invasive treatment of carotid stenosis thus avoiding some of the risks associated with carotid endarterectomy. It is a very important option for those patients who have a higher risk for complications with carotid endarterectomy or for whom
carotid endarterectomy is not an option.

Principal Investigator:

Franklin G. Moser, MD

IRB Approval Number:

6231

Medical Specialty Area:

Interventional Imaging

Condition/Disease:

Carotid Artery Stenosis

IRB Approval Expiration Date:

10/31/2006

Contact Information:

Rene Siegel

Phone: (310) 423-3398

Send Us a Message